S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. Drugs used in
chemotherapy work in different ways to stop the growth of cancer cells, either by killing the
cells or by stopping them from dividing. Giving chemotherapy with a peripheral stem cell
transplant may allow more chemotherapy to be given so that more cancer cells are killed.
Tandem (two) autologous stem cell transplants may be an effective treatment for Hodgkin's
lymphoma.
PURPOSE: This phase II trial is studying how well tandem stem cell transplantation works in
treating patients with progressive or recurrent Hodgkin's lymphoma.